News

Stifel downgraded Baxter International to ‘Hold’ from ‘Buy’ and slashed the price target to $25 from $36. The analysts ...
Baxter International slashed its 2025 profit forecast and posted disappointing quarterly earnings on Thursday, as lingering ...
We came across a bullish thesis on Baxter International Inc. on DeepValue Capital’s Substack. In this article, we will ...
While Baxter International has lagged the broader market over the past year, Wall Street analysts remain cautiously ...
Deerfield-based Baxter International is still feeling battered by Hurricane Helene and problems with its Novum infusion pumps ...
Baxter International (NYSE:BAX) stock drops after the company's Q2 results miss consensus and Q3 projection fails to meet ...
Baxter International cut its 2025 profit forecast on Thursday, while quarterly earnings missed analysts' estimates due to the ...
Detailed price information for Baxter International Inc (BAX-N) from The Globe and Mail including charting and trades.
Baxter International Inc. closed 30.72% below its 52-week high of $40.49, which the company achieved on September 17th.
Baxter International BAX 1.10% is selling its kidney care segment to Carlyle CG 2.06% Group for $3.8 billion, most of which will be paid in cash. The Deerfield, Ill., medical-device maker on ...
Built in the 1970s for medical giant Baxter International, the campus symbolizes a time when sprawling suburban corporate headquarters built in park-like settings were quite the thing.
The stock's fall snapped a four-day winning streak.